Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Boston Plays Host to the Fifth Tecan Symposium

Published: Wednesday, December 12, 2012
Last Updated: Wednesday, December 12, 2012
Bookmark and Share
This year’s symposium explored the topic of ‘Mass spectrometry - the expanding role in life sciences and diagnostics.’

Tecan has recently hosted the fifth annual Tecan Symposium in the picturesque surroundings of Boston, Massachusetts, visiting the US for the first time.

With mass spectrometry (MS) becoming increasingly popular throughout the life sciences sector, from fundamental research to medical diagnostics, the 2012 Tecan Symposium covered a diverse range of MS applications with four main themes: the use of MS in diagnostics and applied markets; the role of MS in basic research; the collection, preparation and storage of samples for MS; and emerging trends and technologies in MS.

Prominent speakers were invited from academia and industry, including Imperial College London and Quest Diagnostics, and spoke on subjects as diverse as medical diagnostics, the value of MS in space science and identifying traces of chocolate on ceramics recovered from archeological sites.

With a wealth of expertise in so many different fields, they provided practical insights into current applications of MS, and discussed the technique’s potential for future applications.

As in previous years, the main scientific program was complemented by a series of social events, including a tour of the Freedom Trail and an evening dinner in Boston Public Library, that allowed delegates to network in an informal atmosphere, contemplating the vast array of MS applications while hailing the success of the fifth Tecan Symposium.

To find out more about the Tecan Symposium, visit

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Tecan and Attana Extend Distribution Agreement
Tecan to distribute Attana's label-free biosensor instruments and QCM assay technology in Europe.
Friday, October 14, 2011
Scientific News
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos